Cargando…
Impaired parasympathetic function in long-COVID postural orthostatic tachycardia syndrome – a case-control study
PURPOSE: Eighty percent of patients infected by SARS-CoV-2 report persistence of one symptom beyond the 4-week convalescent period. Those with orthostatic tachycardia and orthostatic symptoms mimicking postural tachycardia syndrome, they are defined as Long-COVID POTS [LCP]. This case-control study...
Autores principales: | Rigo, Stefano, Urechie, Vasile, Diedrich, Andrè, Okamoto, Luis E., Biaggioni, Italo, Shibao, Cyndya A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481607/ https://www.ncbi.nlm.nih.gov/pubmed/37670400 http://dx.doi.org/10.1186/s42234-023-00121-6 |
Ejemplares similares
-
Symptom Presentation and Access to Medical Care in Patients With Postural Orthostatic Tachycardia Syndrome: Role of Sex
por: Bourne, Kate M., et al.
Publicado: (2021) -
Neurohumoral and haemodynamic profile in postural tachycardia and chronic fatigue syndromes
por: Okamoto, Luis E., et al.
Publicado: (2011) -
Splanchnic Venous Compression Enhances the Effects of ß‐Blockade in the Treatment of Postural Tachycardia Syndrome
por: Smith, Emily C., et al.
Publicado: (2020) -
Long-Term Outcomes of Hyperadrenergic Orthostatic Hypotension
por: Castro, Robert Alexander, et al.
Publicado: (2023) -
Effects of Norepinephrine Reuptake Inhibition on Postural Tachycardia Syndrome
por: Green, Elizabeth A., et al.
Publicado: (2013)